Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Home-based intensive therapy for chronic stroke recovery

Official title: Implementation of a HABIT-ILE Intervention at Home for Individuals With Chronic Stroke: a Non-inferiority Randomized Controlled Trial

Run by Université Catholique de Louvain · NCT05727111 · Data updated 2026-11-12

This study is testing whether a home-based therapy for stroke recovery works as well as traditional therapy to help people regain their movement and independence.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment48 (estimated)
SponsorUniversité Catholique de Louvain
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedMay 1, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2027
Registry record updatedMay 9, 2023
Trial IDNCT05727111 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic stroke who can follow simple instructions and have a caregiver available for therapy sessions.

Probably not a fit

Patients with severe cognitive or visual impairments, uncontrolled seizures, or recent intensive therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of two intensive treatment programs for chronic stroke patients: traditional Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) and a home-based version of the same therapy. It employs a randomized controlled trial design to compare the functional capacities, activities, and social participation of participants receiving these therapies. The study also investigates the impact of follow-up sessions after two weeks of therapy on patient outcomes. By focusing on motor skill learning, the intervention aims to enhance the autonomy of stroke survivors in daily activities.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the functional independence and quality of life for chronic stroke patients.

How similar studies have gone: Preliminary data from other studies suggest that similar intensive therapies have shown promising results in improving outcomes for stroke patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults with a chronic stroke (older than 6 months)
* Ability to interact and understand simple instructions in order to complete assessments and therapy
* Ability to perform a partial shoulder flexion or abduction, a partial elbow extension, and hold an object in the paretic hand
* Availability of a caregiver for 6h30 per day during two weeks of therapy

Exclusion Criteria:

* Non controlled seizure
* Botulinum toxin injection in the last 6 months before the first assessment or during the therapy
* Intensive therapy in the last 6 months before the first assessment or during the therapy
* Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy
* Severe visual or cognitive impairments interfering with treatment and or assessments

Where it's running

  • MSL-IN lab, IoNS, UCLouvain
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.